Boston Scientific Corporation vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Boston Scientific Corporation trades at $51.1 (market cap $74.19B), while Direxion Daily TSLA Bull 2X Shares trades at $8.34. Which is the better fit depends on your goals.
| BSX | TSLL | |
|---|---|---|
Market Cap | $74.19B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $108.14 | $23.03 |
52-Week Low | $42.63 | $6.74 |
Enterprise Value | $86.27B | — |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →